[Prevention of dyslipidemia--the foremost challenge in the management of diabetes].
The most common lipid abnormalities in diabetes, particularly in type II diabetes, are increased levels of triglycerides and reduced levels of HDL (high-density lipoprotein) cholesterol. Recent findings have shown lipid abnormalities to be manifest at an early stage, long before glucose tolerance has become impaired. Much available evidence suggests intensive diabetes therapy to be cost-effective and of importance in preventing micro- and macrovascular complications.